Our mission

We are a group of patients, family, and researchers working together to find effective treatments and ultimately a cure for ASPS.

We fund research, and provide valuable information and a communication platform for patients.

With a disease this rare, information sharing is of paramount importance.

ASPS News

  • Yosef
    August 2, 2023

    iCureASPS is Marking 20 Years of Activity

    The first weekend of August 2023 is marking 20 years of iCureASPS efforts to find a cure for Alveolar Soft Part Sarcoma (ASPS). This weekend “Team ASPS” will ride for the 20th time at the PMC bike ride. Please donate and support our efforts to find a cure for ASPS. Through Saturday and Sunday, August […]

    Read more →
  • ivanandreevich
    April 18, 2023

    CTOS Live Webinar on ASPS Apr 26 2023

    Join us to watch a live webinar on ASPS on Wednesday, April 26, 9:00-11:00 AM Eastern time. Click here to register. 

    Read more →
  • Yosef
    December 17, 2022

    FDA Grants Approval to Atezolizumab for Alveolar Soft Part Sarcoma

    On December 9, 2022, the Food and Drug Administration (FDA) approved atezolizumab (Tecentriq, Genentech, Inc.) for adult and pediatric patients 2 years of age and older with unresectable or metastatic alveolar soft part sarcoma (ASPS). Efficacy was evaluated in Study ML39345 (NCT03141684), an open-label, single-arm study in 49 adult and pediatric patients with unresectable or […]

    Read more →